Bioinformatics.org
[University of Birmingham]
[Patsnap]
Not logged in
  • Log in
  • Bioinformatics.org
    Membership (44629+) Group hosting [?] Wiki
    Franklin Award
    Sponsorships

    Careers
    About bioinformatics
    Bioinformatics jobs

    Research
    All information groups
    Online databases Online analysis tools Online education tools More tools

    Development
    All software groups
    FTP repository
    SVN & CVS repositories [?]
    Mailing lists

    Forums
    News & Commentary
  • Submit
  • Archives
  • Subscribe

  • Jobs Forum
    (Career Center)
  • Submit
  • Archives
  • Subscribe
  • News & Commentary - Message forums

    Resources: Tumor Mutational Burden (TMB) analysis for response to checkpoint immunotherapy
    Submitted by Vivian Creative; posted on Thursday, May 25, 2023

    Tumor mutation burden (TMB) is a prediction of the number of mutations carried by tumor cells and has been paid more and more attention in biomarker research. By measuring TMB, the cancer cell now has a unique fingerprint of natural and mutated proteins. Based on our cutting-edge SuPrecision™ platform, Creative Biolabs has accumulated extensive experience in performing whole exome sequencing (WES) and comprehensive analysis. Our scientists have developed a novel algorithmic approach for TMB analysis for response to checkpoint inhibitor immunotherapy. By comparing DNA sequences from a patient's healthy tissues and tumor cells, our scientists can determine the number of acquired somatic mutations present in tumors but not in normal tissues. We are confident in providing clients with the best service at the most competitive cost.

    https://www.creative-biolabs.com/suprecision/tumor-mutational-burden-tmb-analysis-for-response-to-checkpoint-immunotherapy.htm

    Expanded view | Monitor forum | Save place

    Start a new thread:
    You have to be logged in to post a reply.

     

    Copyright © 2024 Scilico, LLC · Privacy Policy